donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
03613 Beijing Tong Ren Tang Chinese Medicine
12.660
+0.140+1.12%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
569.66% 0.9284 560.41% 0.4196 -78.94% 0.1386 -81.94% 0.0635
Cash Flow Per Share
-35.06% 0.2781 -21.07% 0.5918 -29.42% 0.4282 550.41% 0.7498
Operating Income Per Share
18.31% 1.859 24.08% 0.841 -8.19% 1.5713 -31.01% 0.6778
Net Asset Per Share
13.28% 4.0834 14.88% 3.6854 13.46% 3.6047 -12.51% 3.2081
Basic Earning Per Share
12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27
Diluted  Earning Per Share
12.31% 0.73 18.52% 0.32 -1.52% 0.65 -37.21% 0.27
Profitability
Gross Profit Ratio
-0.69% 71.948% 3.53% 71.042% 2.48% 72.445% -6.03% 68.622%
Operating Profit Ratio
-1.7% 50.024% 4.75% 49.346% 11.83% 50.892% -8.6% 47.108%
Net Profit Ratio
-3.02% 41.869% -0.75% 41.293% 7.22% 43.174% -7.69% 41.606%
Earning Before Tax Ratio
-4.08% 50.020% 0.75% 49.448% 8.39% 52.146% -8.92% 49.079%
ROE
-1.16% 18.890% 3.3% 8.758% -4.38% 19.111% -29.36% 8.478%
ROA
1.29% 16.763% 7.3% 7.712% -6.12% 16.550% -33.06% 7.187%
Yield Quality
Operating Profit To Total Profits
2.47% 100.009% 3.97% 99.793% 3.17% 97.596% 0.35% 95.984%
Tax To Total Profits
5.29% -16.296% -8.31% -16.492% -5.53% -17.206% 6.88% -15.227%
Operating Cash To Total Revenue
466.03% 49.942% 432.27% 49.891% -77.06% 8.823% -73.82% 9.373%
Capital Structure
Debt Assets Ratio
-8.41% 7.705% -27.99% 8.523% -29.16% 8.413% 24.75% 11.836%
Equity Multipler
-0.92% 1.1219 -3.43% 1.1387 -4.04% 1.1324 3.18% 1.1792
Debt Equity Ratio
-9.12% 8.348% -30.6% 9.317% -31.84% 9.185% 28.07% 13.425%
Current Assets To tatal Assets
-0.45% 85.445% 0.56% 85.142% 1.89% 85.835% -0.58% 84.666%
Non Current Assets To Total Assets
2.75% 14.555% -3.1% 14.858% -10.1% 14.165% 3.32% 15.334%
Current Liabilities To tatal Liabilities
-4.31% 72.106% -11.47% 72.624% -8.55% 75.355% 5.2% 82.036%
Non Current Liabilities To Total Liabilities
13.19% 27.894% 52.4% 27.376% 40% 24.645% -18.43% 17.964%
Solvency
Current Ratio
13.59% 15.38 57.75% 13.755 57.27% 13.5398 -24.24% 8.7197
Quick Ratio
18.66% 13.353 59.64% 11.5641 48.59% 11.253 -30.85% 7.2438
Operating Profit To Current Liabilities
18.23% 3.6538 83.78% 1.5977 45.55% 3.0903 -46.78% 0.8693
Operrating Cash Flow To Current Liabilities
580.85% 3.6477 833.83% 1.6153 -70.14% 0.5358 -84.76% 0.173
Share Equity Without Minority Interest To Total Liabilities
10.2% 11.5683 43.8% 10.3034 47.1% 10.4971 -22.31% 7.1651
Operating Cash Flow To Total Liabilities
551.49% 2.6302 726.68% 1.1731 -72.69% 0.4037 -83.96% 0.1419
Operating Profit To Total Liabilities
13.14% 2.6346 62.69% 1.1603 33.11% 2.3287 -44.01% 0.7132
Operating Capacity
Current Assets Turnover(T)
6.25% 0.5012 11.53% 0.2377 -11.26% 0.4717 -25.72% 0.2131
Fixed Assets Turnover(T)
22% 8.3961 27.75% 3.7742 15.57% 6.8822 1.83% 2.9544
Total Assets Turnover(T)
6.94% 0.4292 12.89% 0.2032 -11.63% 0.4013 -26.92% 0.18
Growth Ability
Operating Revenue GR 3Y
-28.35% 2.793% 19.11% -7.307% -87.87% 3.898% -117.45% -9.034%
Gross Income GR 3Y
-42.25% 2.225% -21.77% -6.493% -88.95% 3.852% -110.11% -5.332%
Operating Profit GR 3Y
-3.95% 11.525% 47.24% -8.021% -49.15% 11.999% -131.58% -15.203%
EBT GR 3Y
-34.97% 7.975% 29.02% -9.409% -58.41% 12.264% -124.77% -13.256%
Net Profit GR 3Y
-32.31% 8.352% 21.2% -8.869% -60.38% 12.338% -120.44% -11.256%
Net Profit Attributable To The Parent Company GR 3Y
-56.41% 4.670% -9.58% -13.101% -66.84% 10.713% -121.02% -11.956%
Total Assets GR 3Y
-11.94% 20.936% -19.82% 18.520% -28.55% 23.774% -62.62% 23.097%
Share Equity Without Minority Interest GR 3Y
-16.18% 17.640% -10.79% 17.027% -16.82% 21.044% -67.31% 19.086%
Equity GR 3Y
-14.76% 17.038% -5.25% 16.950% -17.31% 19.988% -67.96% 17.889%
Total Liabilities GR 3Y
14.32% 101.200% -53.91% 38.477% -53.92% 88.525% -46.03% 83.475%
Basic Earning Per Share GR 3Y
-43% 5.797% -4.73% -13.514% -68.22% 10.169% -121.77% -12.903%
Net Assets Per Share GR 3Y
-16.18% 17.640% -10.79% 17.027% -16.82% 21.044% -67.31% 19.086%
Other Indicators
Currency Unit
HKDHKDHKDHKD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Beijing Tongrentang Chinese Medicine Co., Ltd. is mainly engaged in the production and sale of traditional Chinese medicine. The company and its subsidiaries operate through three major divisions. Hong Kong, China Branch is engaged in selling Chinese medicine products and health products through retail stores, providing Chinese medicine diagnostic services and wholesale Chinese medicine products in Hong Kong, China. It is also engaged in managing brand royalties paid by overseas entities that use the "Tongrentang" brand. The mainland China division distributes Tongrentang Technology and Tongrentang brand products exclusively to non-mainland customers in mainland China. Overseas branches retail and wholesale traditional Chinese medicine products and health products in other overseas countries, and provide Chinese medicine diagnosis and treatment services.
CEO: Yongling Ding
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...